New antibacterial agents: patent applications published in 2010

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Patent Analysis

Background:

• Antibacterial resistance necessitates the development of novel antimicrobial agents.
• Patent literature is a key source for identifying emerging drug candidates.
• Understanding recent trends in antibacterial drug discovery is crucial for future research.

Purpose of the Study:

• To review and categorize patent applications from 2010 claiming antibacterial activity for small molecules.
• To identify novel antibacterial compounds based on their biological targets and mechanisms of action.
• To analyze trends in antibacterial drug development, including those addressing resistance mechanisms.

Main Methods:

• Systematic review of patent applications filed in 2010.
• Inclusion criterion: reporting of cellular antibacterial activity data (Minimum Inhibitory Concentrations - MICs).
• Categorization of compounds by biological target (e.g., ribosome, DNA synthesis, cell envelope) and antibacterial class.

Main Results:

• Identified patent applications for various antibacterial classes including protein synthesis inhibitors (50S and 30S ribosome, PDF inhibitors), DNA synthesis inhibitors (GyrA/ParC, GyrB/ParE), and cell envelope disruptors (LpxC, β-lactams, glycopeptides, lipopeptides, polymyxins).
• Covered other classes such as rifamycins, antibacterial peptides, and compounds targeting resistance mechanisms (efflux inhibitors, β-lactamase inhibitors).
• Analysis focused on compounds with reported MIC data, indicating a focus on validated antibacterial activity.

Conclusions:

• The patent landscape in 2010 showed diverse strategies for developing new small molecule antibacterials.
• Significant efforts were directed towards inhibiting essential bacterial processes and overcoming existing resistance mechanisms.
• Patent applications highlight ongoing innovation in the search for effective antibacterial therapies.